| CONTENTS | PAGES | ||
|---|---|---|---|
| Directors' Report | 1-7 | ||
| Independent | Auditors' | Report | 8- 10 |
| Statement of | Financial | Activities | |
| Balance Sheet | 12 | ||
| Statement of | Cash Flows | 13 | |
| Notes forming | part of | the Financial Statements | 14-18 |
| FOR | THE YEAR END | ED 31 MARCH | 2023 | |||
|---|---|---|---|---|---|---|
| Notes | Unrestricted | Restricted | Total | Total | ||
| Funds | Funds | 2023 | 2022 | |||
| 6 | F | 6 | 6 | |||
| Income from: | ||||||
| Donations and grants |
2 | 539,364 | 75,462 | 614,826 | 514,671 | |
| Charitable activities |
3 | 5,655 | 5,655 | 227 | ||
| Other | 104 | 104 | ||||
| Investments - Bank interest | 4 | 4 | ||||
| Total | 545,127 | 75,462 | 620,589 | 514,900 | ||
| Expenditure on: |
||||||
| Charitable activities |
4 | 545,027 | 75,462 | 620,489 | 514,800 | |
| Net income/(expenditure) | 8 | 100 | 100 | 100 | ||
| Transfers between |
funds | |||||
| Net movement in |
funds | 14 | 100 | 100 | 100 | |
| Reconciliation of |
funds | |||||
| Total funds bought | forward | 14 | 410 | 410 | 310 | |
| Total funds canted forward | 14 | 9510 | ENil | 6510 | F410 |
| Notes | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|
| 6 | f | ||||||
| CURRENT ASSETS | |||||||
| Debtors | 12 | 59,088 | 20,906 | ||||
| Cash at bank | and | in | hand | 2,815 | 2,441 | ||
| 61,903 | 23,347 | ||||||
| CREDITORS: | Amounts | falling due | |||||
| within one | year | 13 | 61,393 | 22,937 | |||
| NET ASSETS | 8510 | 6410 | |||||
| Represented | by: | ||||||
| FUNDS | |||||||
| Restricted | Funds | 14 | |||||
| Unrestricted | Funds | 14 | 510 | 410 | |||
| F510 | 6410 |
| 2023 f |
2022 8 |
||||
|---|---|---|---|---|---|
| Cash flows from operating activities |
|||||
| Net movement in funds per statement of |
financial | activities | |||
| Adjustments for. |
|||||
| Investment income - Interest receivable |
(4) | (2) | |||
| (Increase) Idecrease in debtors |
(38,182) | 15,095 | |||
| Increase I (decrease) in creditors |
38,456 | (14,943) | |||
| Net cash provided by /(used In) operating | activides | 370 | 250 | ||
| Cash flows from investing activities |
|||||
| Investment income - Interest received |
|||||
| Net cash provided by investing activities |
|||||
| Change in cash and cash equivalents |
in the year | 374 | 252 | ||
| Cash and cash equivalents brought forward |
2,189 | ||||
| Cash and cash equivalents carried forward |
F2,815 | E2,441 | |||
| Analysis ofcash and cash equivalents | 2023 | 2022 | |||
| Cash at bank and in hand |
K2,815 |
| lcontd. .. | |||||
|---|---|---|---|---|---|
| DONATIONS | AND GRANTS | Unrestricted | Restricted | Total | Total |
| funds F |
Funds f |
2023 6 |
2022 | ||
| Grants | |||||
| Alliance House Foundation | 539,364 | 539,364 | 44'I,259 | ||
| Cancer Research UK |
29,110 | 29,110 | 25,440 | ||
| World Health | Organisation | 10,206 | |||
| Institute ofSocial Marketing | 3,000 | 3,000 | 4,608 | ||
| British Academy Research Project | 9,400 | 9,400 | |||
| Health Lumen |
6,569 | ||||
| Alcohol Health | Alliance | 10,000 | 10,000 | 16,589 | |
| Donations | |||||
| Alcohol Health | Alliance | 23,952 | 23,952 | 10,000 | |
| F539,364 | 675,462 | 6614,826 | 8514,671 |
| Of the 6514,671 recognised in restricted funds. |
Of the 6514,671 recognised in restricted funds. |
Of the 6514,671 recognised in restricted funds. |
2022, F441 | ,259 related to un |
restricted fu |
nds and 673, |
412 related | |
|---|---|---|---|---|---|---|---|---|
| 3. | INCOME FROM CHARITABLE | ACTIVITIES | Unrestricted | Restricted | Total | Total | ||
| funds f |
funds 6 |
2023 6 |
2022 f |
|||||
| Alcohol Conference | Arrangement | Fee | 5,605 | 5,605 | ||||
| Sundry Income |
50 | 50 | 227 | |||||
| 65,655 | 6Nil | 25,655 | F227 | |||||
| All ofthe 6227 recognised | in 2022 related to | unrestricted funds. |
||||||
| 4. | EXPENDITURE ON | CHARITABLE | Direct | Support | Total | Total | ||
| ACTIVITIES | costs | costs | 2023 | 2022 | ||||
| Research and dissemination | f464,438 | 6156,051 | f620,489 | F514,800 |
| Of the 6514,800 expenditure recognised in 2022, F4 673,512was charged to restricted funds. |
Of the 6514,800 expenditure recognised in 2022, F4 673,512was charged to restricted funds. |
Of the 6514,800 expenditure recognised in 2022, F4 673,512was charged to restricted funds. |
Of the 6514,800 expenditure recognised in 2022, F4 673,512was charged to restricted funds. |
41,288 was charged to unrestrict |
ed funds a |
|---|---|---|---|---|---|
| ANALYSIS OF DIRECT COSTS | 2023 | 2022 | |||
| 8 | |||||
| Wages | and salaries | 405,845 | 362,655 | ||
| Advisory | panel | 7,000 | 7,000 | ||
| Travel, | conferences | and symposia | 6,595 | 2,832 | |
| Website | redesign | and development | 100 | ||
| Media Monitoring | 4,275 | 3,968 | |||
| Publications and |
subscriptions | 40,723 | 13,712 | ||
| f464,438 | F390,287 |
| ANALYSIS OF SUPPORT COST | S | 2023 E |
2022f |
| Wages and salaries | 15,906 | 10,996 | |
| Staff training and recruitment |
2,905 | 5,071 | |
| Office rent &service charge | 88,741 | 70,566 | |
| Office costs | 25,930 | 18,859 | |
| IT and computer costs | 18,845 | 17,001 | |
| Governance costs (see Note 7) |
3,724 | 2,040 | |
| F156,051 | 8124,533 | ||
| GOVERNANCE COSTS | 2023 | 2022 | |
| f. | 8 | ||
| Audit fees and related costs | 948 | 2,040 | |
| Directors' meetings |
2,776 | ||
| 53,724 | |||
| NET INCOME/(EXPENDITURE) | FOR THE YEAR | 2023 | 2022 |
| This is stated after charging: Auditor's remuneration —audit services |
f978 | E2,040 | |
| STAFF COSTS AND NUMBERS | 2023 | 2022 | |
| 5 | E | ||
| Salaries | 340,248 | 305,630 | |
| Social security costs | 32,443 | 29,709 | |
| Pension costs | 48,690 | 37,783 | |
| Other costs | 370 | 529 | |
| 8421,751 | 2373,651 |
| 12. | DEBTORS | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Prepayments | and | other debtors | 659,088 | 820,906 | ||||
| 13. | CREDITORS: | Amounts falling due |
within one year | 2023 | 2022 | |||
| 6 | 5 | |||||||
| Accruals | 3,364 | 5,320 | ||||||
| Other creditors | 58,029 | 17,617 | ||||||
| 661,393 | 822,937 | |||||||
| 14. | RESERVES | Balance | Balance | |||||
| at | at | |||||||
| 1 April | 31 March | |||||||
| 2023 | 2022 | Income | Expenditure | Transfers | 2023 | |||
| Restricted funds | ||||||||
| Alcohol Health | Alliance Project | 33,952 | 33,952 | |||||
| Cancer Research | UK | 29,110 | 29,110 | |||||
| British Academy | Research Project | 9,400 | 9,400 | |||||
| Institute ofSocial | Marketing | 3,000 | 3,000 | |||||
| 75,462 | 75,462 | |||||||
| Unrestricted | Funds | |||||||
| General funds | 410 | 545,127 | 545,027 | 510 | ||||
| f410 | 6545,127 | f545,027 | 6Nil | 6510 |
| Compar | ative infor |
mation for the pre |
vious financial |
year is as fo | llows: | ||
|---|---|---|---|---|---|---|---|
| Balance at | Balance at | ||||||
| 1 April | 31 March | ||||||
| 2022 | 2021 | income | Expenditure | Transfers | 2022 | ||
| Restricted funds | |||||||
| Alcohol | Health Alliance Project | 26,589 | 26,589 | ||||
| Cancer | Research | UK | 25,440 | 25,440 | |||
| World Health Organisation | 10,206 | 10,206 | |||||
| Institute | ofSocial | Marketing | 4,608 | 4,608 | |||
| Health | Lumen | 6,569 | 6,569 | ||||
| Alliance | House Foundation | 100 | 100 | ||||
| 73,412 | 73,512 | ||||||
| Unrestricted Funds |
|||||||
| General | funds | 210 | 441,488 | 441,288 | 410 | ||
| 8310 | 8514,900 | F514,800 | ENII | F410 | |||
| RELATED PARTY TRANSACTIONS | |||||||
| Details | of related | party transactions | during the year are as follows: |
||||
| Name of related | party | Nature of | Transaction | ||||
| relationship | details | Amount | Balance | ||||
| E | |||||||
| 2023 | |||||||
| Alliance | House Foundation | Connected | Grant | ||||
| charity | funding | 539,364 | (28,290) | ||||
| Alliance | House Foundation | Connected | Rent | ||||
| charity | payable | 63,500 | |||||
| 2022 | |||||||
| Alliance | House Foundation | Connected | Grant | ||||
| charity | funding | 441,259 | 8,589 | ||||
| Alliance | House Foundation | Connected | Rent | ||||
| charity | payable | 54,637 |